- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01261676
Current Dutch Practice on Caesarean Sections: Identification of Barriers and Facilitators for Optimal Care (SIMPLE)
Current Dutch Practice on Caesarean Sections: Identification of Barriers and Facilitators for Optimal Care.
Caesarean (CS) delivery rates in the Netherlands increased from 5 to 15% the last 20 years. CSs have no clear benefit for overall neonatal outcome and are associated with higher maternal complications and high costs. Dutch guidelines offer clear recommendations on factors that have a direct effect on the decision to perform a CS.
Hypothesis: there is incomplete adherence to the recommendations from the guidelines on CS among Dutch gynaecologists.
This study consists of four phases:
- Development of quality indicators: A set of quality indicators regarding the process, structure and outcome of care will be developed according to the RAND-modified Delphi method. A representative, national expert panel consisting of 12 to 15 obstetricians and midwives will participate.
- Current care study: The current Dutch care will be studied in 20 hospitals (N=80 gynaecologists). 1000 files on performed CSs are analyzed regarding the adherence to the developed quality indicators. To get insight into Dutch practices compared to international data, basic obstetrical data will be extracted from the delivery database.
- Barrier analysis: A barrier analysis will be carried out based on the results of the current care study. Two groups of hospitals will be identified in the upper and lower extremes of the 'adherence distribution': 5 hospitals with the lowest and 5 hospitals with the highest adherence scores. Factors that determine the decision to perform a CS or not (barriers and facilitators) will be analyzed in both groups using semi-structured interviews among 15-20 professionals and 15-20 patients. A questionnaire will be used to study the 'prevalence' of these factors among all obstetric gynaecologists in the Netherlands and among 200 patients.
- Controlled before- and-after (CBA) study: Based on the outcomes of the current care study and the barrier analysis, a tailor made implementation strategy will be developed in order to increase adherence to the CS quality indicators. Target groups will be selected with focus on women with both a high incidence of the indicator and low indicator adherence. The strategy will be executed and evaluated in a CBA-study in 12 hospitals (6 intervention, 6 control) in terms of effectiveness, experiences and costs. The sample size will be dependent on the target group and adherence to the quality indicators regarding this target group. These data will be available after performing the current care and the barrier study.
Přehled studie
Typ studie
Zápis (Očekávaný)
Kontakty a umístění
Studijní místa
-
-
-
Almelo, Holandsko
- Ziekenhuisgroep Twente
-
Almere, Holandsko
- Flevo ziekenhuis
-
Amersfoort, Holandsko
- Meander Medisch Centrum
-
Amsterdam, Holandsko
- Academisch Medisch Centrum
-
Apeldoorn, Holandsko
- Gelreziekenhuizen
-
Arnhem, Holandsko
- Rijnstate Ziekenhuis
-
Capelle aan den Ijjsel, Holandsko
- IJsselland ziekenhuis
-
Eindhoven, Holandsko
- Catharina-ziekenhuis
-
Groningen, Holandsko
- University Medical Centre Groningen
-
Hardenberg, Holandsko
- Ropcke-Zweers Ziekenhuis
-
Heerlen, Holandsko
- Atrium Medisch Centrum Parkstad
-
Helmond, Holandsko
- Elkerliek Ziekenhuis
-
Hilversum, Holandsko
- Tergooiziekenhuizen
-
Maastricht, Holandsko
- Maastricht Universitair Medisch Centrum
-
Nijmegen, Holandsko
- Universitair Medisch Centrum St. Radboud
-
Sittard, Holandsko
- Orbis Medisch Centrum
-
Utrecht, Holandsko
- Universitair Medisch Centrum Utrecht
-
Veldhoven, Holandsko
- Maxima Medisch Centrum
-
Weert, Holandsko
- Sint Jansgasthuis
-
Zaandam, Holandsko
- Zaans Medisch Centrum
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
- Development of quality indicators: 12-15 obstetricians and midwives
- Current care study: All women (1000) who underwent a CS in one of the 20 participating hospitals during the study period (3-4 months). All hospitals participate in the Dutch consortium and consist of university teaching-, non-university teaching- and non-university-non-teaching hospitals.
- Barrier analysis: Qualitative: 15-20 professionals and 15-20 patients from the hospitals in the upper and lower extremes of the 'adherence distribution'. Quantitative: obstetricians in the Netherlands and 200 experienced patients.
- CBA study: depending on the outcome of phase 2 and 3 of the study, the implementation strategy will be designed for a target group with low guideline adherence and high incidence.
Popis
Inclusion Criteria:
- A previous caesarean section in a 3-4 month time period.
Exclusion Criteria:
- Major congenital malformality
- Fetal death prior to onset of delivery
- Duration of pregnancy less than 24 weeks of gestation
Studijní plán
Jak je studie koncipována?
Detaily designu
Kohorty a intervence
Skupina / kohorta |
Intervence / Léčba |
---|---|
Caesarean section
|
An implementation strategy to improve outcome for women in labour will be developed depending on the outcome of the current care study and the barrier and facilitator analysis.The strategy will be executed and evaluated in a controlled before-and-after study in 12 hospitals (6 intervention, 6 control)
|
Vaginal birth (control)
|
An implementation strategy to improve outcome for women in labour will be developed depending on the outcome of the current care study and the barrier and facilitator analysis.The strategy will be executed and evaluated in a controlled before-and-after study in 12 hospitals (6 intervention, 6 control)
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Časové okno |
---|---|
1) Development of quality indicators: development of a valid set of quality indicators for measuring current Dutch care on caesarean sections
Časové okno: December 2010 - October 2013
|
December 2010 - October 2013
|
2) Current care study: The main outcome is the adherence to the quality indicators regarding the process, structure and outcome (maternal and fetal) of care
Časové okno: December 2010 - October 2013
|
December 2010 - October 2013
|
3) Barrier and facilitator analysis: Identification of barriers and facilitators to perform a caesarean section
Časové okno: December 2010 - October 2013
|
December 2010 - October 2013
|
4) Controlled before-and-after study: effectiveness of the implementation strategy defined as observed increase in adherence between the intervention and control hospitals and actual CS rates in both groups
Časové okno: December 2010 - October 2013
|
December 2010 - October 2013
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
1) Development of quality indicators: no secondary outcomes
Časové okno: December 2010 - October 2013
|
December 2010 - October 2013
|
|
2) Current care study: International comparison
Časové okno: December 2010- October 2013
|
Dutch practice as compared to international data (Robson criteria)
|
December 2010- October 2013
|
3) Barrier and facilitator analysis: no secondary outcomes
Časové okno: December 2010-October 2013
|
December 2010-October 2013
|
|
4) Controlled before-and-after study: experiences and satisfaction of health care providers and patients with the implementation strategy and applicability and costs of the strategy
Časové okno: December 2010-October 2013
|
December 2010-October 2013
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Hubertina CJ Scheepers, Ph.D., Maastricht University Medical Center
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Očekávaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další identifikační čísla studie
- 09-4-047
- 17100.3006 (Jiné číslo grantu/financování: zonMW)
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Implementation aids
-
Boise State UniversityU.S. Department of JusticeDokončenoProblémové chováníSpojené státy
-
Nemours Children's ClinicChildren's Hospital of Philadelphia; American Cancer Society, Inc.Aktivní, ne náborDětská rakovinaSpojené státy
-
Ontario HIV Treatment NetworkMcMaster UniversityNeznámýPoužití výzkumných důkazůKanada
-
University of California, San FranciscoSan Francisco Jail Health Services - HIV and Integrated Services; San Francisco...Dokončeno
-
Centers for Disease Control and PreventionPublic Health Management CorporationDokončenoHIV infekceSpojené státy
-
University of Illinois at ChicagoNational Institute on Minority Health and Health Disparities (NIMHD)DokončenoHIV/AIDSSpojené státy
-
London School of Hygiene and Tropical MedicineDepartment for International Development, United Kingdom; University of Witwatersrand... a další spolupracovníciDokončenoHIV infekce | Násilí založené na pohlavíJižní Afrika
-
Columbia UniversityAmerican Institutes for Research; German Development CorporationDokončeno
-
Columbia UniversityNational Institute of Mental Health (NIMH); University of Cape TownNáborHIV | Expozice traumatuJižní Afrika
-
CSL BehringDokončenoZískaný deficit koagulačního faktoruRakousko, Německo, Maďarsko, Izrael, Litva, Holandsko, Polsko, Švýcarsko